Inventor · disambiguated record
Alexander Minidis
Also filed as: MINIDIS ALEXANDER · MINIDIS ALEXANDER BOGDAN EMIL
6 granted patents·14 pending applications·24 citations·filing 2003–2023
78Inventor score
Files withASTRAZENECA AB8NPS PHARMA INC5ASTRAZENECA AND NPS PHARMACEUT2MINIDIS ALEXANDER2ATTGENO AB1
Top patents by PatentIndex Score
20 records- 0185US7476684B2Compounds for the treatment of neurological, psychiatric or pain disordersASTRAZENECA AB·Filed 2006·Granted Jan 13, 2009·11 cites·5 claims
- 0282US7456200B2CompoundsASTRAZENECA AB·Filed 2005·Granted Nov 25, 2008·9 cites·11 claims
- 0372US7576077B2Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 0468US12486216B2Processes for preparing nitrosylated propanediols, compositions comprising the same, and medical uses thereofATTGENO AB·Filed 2019·Granted Dec 2, 2025·1 cites·11 claims
- 0562US9145380B2Bis-(sulfonylamino) derivatives for use in therapyBYLUND JOHAN·Filed 2008·Granted Sep 29, 2015·1 cites·14 claims
- 0657US2024199585A1Solid forms of (3r)-n-[2-cyano-4-fluoro-3-(3-methyl-4-oxo-quinazolin-6-yl)oxy-phenyl]-3-fluoro-pyrrolidine-1-sulfonamideHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0757US2007179188A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 0853US2007270469A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 0953US2007270468A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 1053US2009163586A1Bis-(Sulfonylamino) Derivatives in Therapy 205ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1152US2008312240A1Bicyclic Piperazines as Metabotropic Glutatmate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1252US2007037816A1Bicyclic piperazines as metabotropic glutatmate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 1349US7691892B2Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Apr 6, 2010·0 cites·22 claims
- 1448US2006019997A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 1548US2007185178A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 1648US2007197549A1Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1745US2004152699A1CompoundsASTRAZENECA AND NPS PHARMACEUT·Filed 2003·Application pending·0 cites
- 1842US2005004130A1New metabotropic glutamate receptor compoundsASTRAZENECA AND NPS PHARMACEUT·Filed 2004·Application pending·0 cites
- 1941US2011224261A1Crystalline form of 4-(5--4-methyl-4h-1,2,4-triazol-3-yl)pyridineASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 2040US2007185095A1Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →